Shilpa Pharma is a leading polymer manufacturer in India, specializing in the development and supply of high-quality pharmaceutical polymers such as PBD-B-PEO (Polybutadiene-block-Polyethylene oxide) and other custom polymers. With state-of-the-art R&D capabilities and GMP-compliant facilities, we provide innovative polymer solutions that support both oncology and non-oncology formulations.
Our polymers play a vital role in enhancing drug solubility, stability, and delivery efficiency across a wide range of therapeutic areas. Backed by strong expertise in polymer synthesis, characterization, and scale-up, we cater to global pharmaceutical companies with reliable and tailor-made solutions.
At Shilpa Pharma, we ensure strict adherence to international regulatory standards, providing comprehensive documentation and IPR support for global submissions. With a commitment to innovation, quality, and sustainability, we continue to advance as one of the most trusted names among polymer suppliers in the pharmaceutical industry.
For Polymer Enquiries mail us on:
info@shilpapharma.com
| Polymers for Pharma & Biomedical Applications | ||||
|---|---|---|---|---|
| S. NO. | PRODUCT NAME | M.Wt kDa | Application | CAS No |
| 1 | Methoxy polyethylene glycol (mPEG) |
5, 10 & 20 | FOR DRUG DELIVERY, Peptide & Protein APPLICATIONS | 9004-74-4 |
| 2 | MONODISPERSE POLYETHYLENE GLYCOL |
PEG-9, PEG-8 | ADC Applications | 25322-68-3 |
| 3 | POLYLACTIDES |
5, 10, 20 | For Long acting Deliverable applications | 26100-51-6 |
| 4 | Poly(lactide-co-glycolide) (PLGA) |
10, 20, 40 & 50 | For Long acting Deliverable applications | 26780-50-7 |
| 5 | SILICON BASED COPOLYMERS |
5, 10, 30 kDa | Pressure sensitive Adhesive | - |
| 6 | POLYOXAZOLINE |
5, 10, 20 kDa | For Drug DELIVERY | 25805-17-8 |
| 7 | POLYETHYLENIMINE HYDROCHLORIDE |
5, 10, 20 | For gene delivery applications | 25987-06-8 |
| 8 | POLYETHYLENIMINE |
5, 10 kDa | For gene delivery applications | 9002-98-6 |
| 9 | poly(N-isopropylacrylamide) |
10, 20, 40 & 80 | For Drug Deliver Applications | 25189-55-3 |
| 10 | Polyacrylic acid/ Sodium Polyacrylate |
100 | Superabsorbants | 9003-01-4 |
| 11 | Polyvinyl alcohol |
50 | Biomedical Applications | 9002-89-5 |
| 12 | Poly(N,N-dimethylacrylamide) |
10, 20 & 100 | Drug delivery & Biomedical applications | 26793-34-0 |
| 13 | Polyacrylate copolymers |
upto 100 | Biomedical Applications | 25133-97-5 |
| 14 | Polylutamic Acid |
5, 10 | Drug delivery | 25513-46-6 |

From synthesis to functionalization, we deliver polymers for advanced drug delivery and medical devices.

Specialized PBD-b-PEO polymers for controlled release and targeted therapies.

State-of-the-art facilities ensure scalable, compliant, and high-quality polymer production.
Leading the Way in Pharma Innovation

Established

R&D workforce

Team size

Manufacturing site

Audits

Customers

Projects
Shilpa Pharma develops and manufactures specialized pharmaceutical polymers such as Polybutadiene-block-Polyethylene Oxide (PBD-b-PEO) at advanced cGMP-compliant facilities in India. As a trusted partner offering CDMO services in India, our manufacturing blocks are equipped to deliver high-quality polymers that meet the stringent requirements of international regulatory authorities including USFDA, EU GMP, ANVISA, COFEPRIS, TGA, PMDA, and KFDA, making them suitable for use in global markets.
Our dedicated R&D team applies expertise in polymer synthesis, process development, and formulation sciences to create innovative polymer solutions that support a wide range of therapeutic applications, from oncology to advanced drug delivery systems. Each polymer undergoes rigorous characterization and analytical testing to ensure optimal purity, stability, and performance.
By integrating cutting-edge polymer science with scalable manufacturing, Shilpa Pharma empowers pharmaceutical companies worldwide to develop safe, effective, and reliable therapies. With a strong focus on quality, regulatory compliance, and innovation, and by providing end-to-end CDMO services in India, we continue to expand our polymer portfolio to meet the evolving needs of the global healthcare industry.
India has emerged as a global hub for high-performance polymers used in pharmaceutical, biomedical, and specialty chemical applications. With increasing demand for advanced excipients, drug delivery polymers, and functional materials, global buyers are actively seeking reliable polymers manufacturers in India that can meet stringent quality, regulatory, and scalability requirements.
Shilpa Pharma is a trusted name among leading polymers manufacturers in India, offering a broad portfolio of pharmaceutical and biomedical-grade polymers. Backed by strong R&D, GMP-compliant manufacturing facilities, and decades of pharmaceutical expertise, Shilpa Pharma serves regulated and semi-regulated markets worldwide.
As a reputed polymers supplier in India, we understand the critical needs of B2B customers — batch-to-batch consistency, regulatory documentation, technical support, and reliable long-term supply. Our polymer solutions are designed to support complex drug formulations, novel delivery systems, and advanced biomedical applications.
For companies looking to partner with a dependable Indian polymer manufacturer with global compliance standards, Shilpa Pharma offers a scalable, quality-driven, and innovation-focused solution.
Pharmaceutical polymers are high-molecular-weight compounds used extensively in drug formulation, controlled drug delivery, biomedical devices, and tissue engineering. These polymers can be natural, semi-synthetic, or synthetic, and are selected based on their solubility, biodegradability, biocompatibility, and functional performance.
In the pharmaceutical industry, polymers play a vital role as binders, film-formers, release modifiers, stabilizers, and carriers for active pharmaceutical ingredients (APIs). Their ability to enhance drug stability, bioavailability, and patient compliance makes them indispensable in modern drug development.
As one of the established polymers manufacturers in India, Shilpa Pharma develops and supplies polymers that align with global pharmacopoeial and regulatory expectations.
As a globally trusted polymers supplier in India, Shilpa Pharma operates manufacturing facilities that comply with the highest international regulatory and quality standards. Our robust quality systems ensure that every polymer batch meets stringent regulatory, safety, and performance criteria.
Our manufacturing facilities are:
These approvals enable Shilpa Pharma to support clients across regulated and semi-regulated global markets with confidence.
When sourcing high-quality pharmaceutical and biomedical polymers, global companies prioritize technical expertise, regulatory compliance, and long-term reliability. Shilpa Pharma stands out among polymers manufacturers in India by offering integrated capabilities as a leading CDMO pharma company in India.
As an experienced Contract Development and Manufacturing Organization (CDMO), Shilpa Pharma collaborates closely with pharmaceutical innovators, generic manufacturers, and biotech companies. From early-stage development to commercial-scale manufacturing, we provide end-to-end polymer solutions tailored to specific formulation and delivery needs.
Our CDMO services include:
We go beyond being a supplier — we act as a strategic CDMO partner focused on accelerating your product development and commercialization.
Shilpa Pharma is a preferred polymers supplier in India for pharmaceutical and life sciences companies across Europe, Japan, China, the Americas, and other international markets. Our global reputation is built on consistent quality, transparent communication, and regulatory excellence.
Why international clients choose Shilpa Pharma:
Our long-standing global partnerships reflect our commitment to quality, trust, and long-term collaboration.
With advanced manufacturing infrastructure in India, Shilpa Pharma combines cost-effective operations with world-class quality standards. Our GMP-compliant facilities are equipped to manufacture a wide range of pharmaceutical and biomedical polymers across diverse molecular weights and specifications.
This strong manufacturing foundation positions Shilpa Pharma as one of the most reliable polymers manufacturers in India and a preferred CDMO pharma company in India for global pharmaceutical innovators.
Get our capability overview via email